Explore the words cloud of the ANTIVIRALS project. It provides you a very rough idea of what is the project "ANTIVIRALS" about.
The following table provides information about the project.
Coordinator |
UNIVERSITEIT UTRECHT
Organization address contact info |
Coordinator Country | Netherlands [NL] |
Project website | http://www.antivirals-etn.eu |
Total cost | 3˙837˙214 € |
EC max contribution | 3˙837˙214 € (100%) |
Programme |
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers) |
Code Call | H2020-MSCA-ITN-2014 |
Funding Scheme | MSCA-ITN-ETN |
Starting year | 2015 |
Duration (year-month-day) | from 2015-03-01 to 2019-09-30 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | UNIVERSITEIT UTRECHT | NL (UTRECHT) | coordinator | 510˙748.00 |
2 | CARDIFF UNIVERSITY | UK (CARDIFF) | participant | 546˙575.00 |
3 | UNIVERSITE D'AIX MARSEILLE | FR (Marseille) | participant | 525˙751.00 |
4 | ACADEMISCH ZIEKENHUIS LEIDEN | NL (LEIDEN) | participant | 510˙748.00 |
5 | UNIVERSITATSKLINIKUM HEIDELBERG | DE (HEIDELBERG) | participant | 498˙432.00 |
6 | KATHOLIEKE UNIVERSITEIT LEUVEN | BE (LEUVEN) | participant | 402˙055.00 |
7 | VIROVET | BE (LEUVEN) | participant | 250˙560.00 |
8 | AICURIS GMBH & CO. KG | DE (WUPPERTAL) | participant | 249˙216.00 |
9 | UNIVERSITAT WIEN | AT (WIEN) | participant | 244˙061.00 |
10 | COMPLIX LUXEMBOURG SA | LU (LUXEMBOURG) | participant | 99˙063.00 |
11 | ARATANA THERAPEUTICS NV | BE (HEVERLEE) | participant | 0.00 |
12 | COMPLIX NV | BE (DIEPENBEEK) | participant | 0.00 |
13 | Virology Education | NL (Utrecht) | partner | 0.00 |
Viral infections are a major cause of disease, mortality and economic losses worldwide. Antiviral therapy is an essential instrument to control virus infections. At present, however, licensed antiviral drugs have been developed only against a limited number of viruses (e.g. HIV, HCV, influenza, herpesviruses). There is a clear and unmet need for antiviral drugs to treat infections with other important human pathogens.
Europe needs well-trained experts with multidisciplinary skills to advance the antiviral drug development field. However, few, if any, European universities or research institutes have the ability to deliver an intersectoral training programme that covers the broad spectrum of disciplines important for antiviral drug development.
The ANTIVIRALS partnership has been established to fill this gap. It consists of six outstanding European academic partners and four industrial partners (two large R&D companies, of which one is specialized in antiviral drug discovery and development, and two SMEs), and two partner organisations (incl. one SME specialised in education). All partners are leaders in their field, ensuring state-of-the-art training possibilities, and their skills are highly complementary.
ANTIVIRALS aims to introduce 15 ESRs to state-of-the-art knowledge and technology applied in antiviral drug development through both local and network-wide training activities. Individual research projects, research training workshops and intersectoral secondments will be supplemented with complementary skills courses and dissemination activities to improve career development and perspectives. The industrial partners are actively involved in the entire programme and will organize an industry-oriented conference aimed at further bridging the gap between academia and industry.
Thus, ANTIVIRALS offers talented researchers a multidisciplinary and intersectoral training programme and prepares them for a future leading role in antiviral drug development in Europe.
ESR weblog | Websites, patent fillings, videos etc. | 2020-02-27 15:43:43 |
PhD Thesis Titles & Degrees | Documents, reports | 2020-02-27 15:43:43 |
International conference | Other | 2020-02-27 15:43:43 |
Recruitment | Other | 2019-10-29 16:55:23 |
ANTIVIRALS website | Websites, patent fillings, videos etc. | 2019-10-29 16:55:24 |
Take a look to the deliverables list in detail: detailed list of ANTIVIRALS deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2018 |
François Ferron, Lorenzo Subissi, Ana Theresa Silveira De Morais, Nhung Thi Tuyet Le, Marion Sevajol, Laure Gluais, Etienne Decroly, Clemens Vonrhein, Gérard Bricogne, Bruno Canard, Isabelle Imbert Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA published pages: E162-E171, ISSN: 0027-8424, DOI: 10.1073/pnas.1718806115 |
Proceedings of the National Academy of Sciences 115/2 | 2019-11-22 |
2017 |
Charlotte E. Melia, Hilde M. van der Schaar, Heyrhyoung Lyoo, Ronald W.A.L. Limpens, Qian Feng, Maryam Wahedi, Gijs J. Overheul, Ronald P. van Rij, Eric J. Snijder, Abraham J. Koster, Montserrat Bárcena, Frank J.M. van Kuppeveld Escaping Host Factor PI4KB Inhibition: Enterovirus Genomic RNA Replication in the Absence of Replication Organelles published pages: 587-599, ISSN: 2211-1247, DOI: 10.1016/j.celrep.2017.09.068 |
Cell Reports 21/3 | 2019-11-22 |
2017 |
Heyrhyoung Lyoo, Cristina M. Dorobantu, Hilde M. van der Schaar, Frank J.M. van Kuppeveld Modulation of proteolytic polyprotein processing by coxsackievirus mutants resistant to inhibitors targeting phosphatidylinositol-4-kinase IIIβ or oxysterol binding protein published pages: 86-90, ISSN: 0166-3542, DOI: 10.1016/j.antiviral.2017.10.006 |
Antiviral Research 147 | 2019-11-22 |
2017 |
Jih Ru Hwu, Nitesh K. Gupta, Shwu-Chen Tsay, Wen-Chieh Huang, Irina C. Albulescu, Kristina Kovacikova, Martijn J. van Hemert Bis(benzofuran–thiazolidinone)s and bis(benzofuran–thiazinanone)s as inhibiting agents for chikungunya virus published pages: 96-101, ISSN: 0166-3542, DOI: 10.1016/j.antiviral.2017.08.008 |
Antiviral Research 146 | 2019-11-22 |
2016 |
Rachel Ulferts, S. Matthijn de Boer, Lonneke van der Linden, Lisa Bauer, Hey Rhyoung Lyoo, Maria J. Maté, Julie Lichière, Bruno Canard, Daphne Lelieveld, Wienand Omta, David Egan, Bruno Coutard, Frank J. M. van Kuppeveld Screening of a Library of FDA-Approved Drugs Identifies Several Enterovirus Replication Inhibitors That Target Viral Protein 2C published pages: 2627-2638, ISSN: 0066-4804, DOI: 10.1128/AAC.02182-15 |
Antimicrobial Agents and Chemotherapy 60/5 | 2019-11-22 |
2017 |
Irina C. Albulescu, Kristina Kovacikova, Ali Tas, Eric J. Snijder, Martijn J. van Hemert Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles published pages: 230-236, ISSN: 0166-3542, DOI: 10.1016/j.antiviral.2017.04.016 |
Antiviral Research 143 | 2019-11-22 |
2017 |
Tassini S, Sun L, Lanko K, Crespan E, Langron E, Falchi F, Kissova M, Armijos-Rivera JI, Delang L, Mirabelli C, Neyts J, Pieroni M, Cavalli A, Costantino G, Maga G, Vergani P, Leyssen P, Radi M Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases. published pages: 1400-1416, ISSN: 0022-2623, DOI: 10.1021/acs.jmedchem.6b01521 |
J Med Chem 60(4) | 2019-11-22 |
2017 |
Lisa Bauer, Heyrhyoung Lyoo, Hilde M van der Schaar, Jeroen RPM Strating, Frank JM van Kuppeveld Direct-acting antivirals and host-targeting strategies to combat enterovirus infections published pages: 1-8, ISSN: 1879-6257, DOI: 10.1016/j.coviro.2017.03.009 |
Current Opinion in Virology 24 | 2019-11-22 |
2017 |
Kristina Lanko, Kristel Eggermont, Abdulsamie Patel, Suzanne Kaptein, Leen Delang, Catherine M. Verfaillie, Johan Neyts Replication of the Zika virus in different iPSC-derived neuronal cells and implications to assess efficacy of antivirals published pages: 82-86, ISSN: 0166-3542, DOI: 10.1016/j.antiviral.2017.07.010 |
Antiviral Research 145 | 2019-11-22 |
2016 |
Cristina M. Dorobantu, Lucian Albulescu, Heyrhyoung Lyoo, Mirjam van Kampen, Raffaele De Francesco, Volker Lohmann, Christian Harak, Hilde M. van der Schaar, Jeroen R. P. M. Strating, Alexander E. Gorbalenya, Frank J. M. van Kuppeveld Mutations in Encephalomyocarditis Virus 3A Protein Uncouple the Dependency of Genome Replication on Host Factors Phosphatidylinositol 4-Kinase IIIα and Oxysterol-Binding Protein published pages: e00068-16, ISSN: 2379-5042, DOI: 10.1128/mSphere.00068-16 |
mSphere 1/3 | 2019-11-22 |
2017 |
Jeroen RPM Strating, Frank JM van Kuppeveld Viral rewiring of cellular lipid metabolism to create membranous replication compartments published pages: 24-33, ISSN: 0955-0674, DOI: 10.1016/j.ceb.2017.02.005 |
Current Opinion in Cell Biology 47 | 2019-11-07 |
2019 |
Susan Schuster, Gijs J. Overheul, Lisa Bauer, Frank J. M. van Kuppeveld, Ronald P. van Rij No evidence for viral small RNA production and antiviral function of Argonaute 2 in human cells published pages: , ISSN: 2045-2322, DOI: 10.1038/s41598-019-50287-w |
Scientific Reports 9/1 | 2019-11-07 |
2019 |
Vladimira Horova, Heyrhyoung Lyoo, Bartosz Różycki, Dominika Chalupska, Miroslav Smola, Jana Humpolickova, Jeroen R. P. M. Strating, Frank J. M. van Kuppeveld, Evzen Boura, Martin Klima Convergent evolution in the mechanisms of ACBD3 recruitment to picornavirus replication sites published pages: e1007962, ISSN: 1553-7374, DOI: 10.1371/journal.ppat.1007962 |
PLOS Pathogens 15/8 | 2019-10-03 |
2019 |
Liang Sun, Hyunwook Lee, Hendrik Jan Thibaut, Kristina Lanko, Eva Rivero-Buceta, Carol Bator, Belen Martinez-Gualda, Kai Dallmeier, Leen Delang, Pieter Leyssen, Federico Gago, Ana San-Félix, Susan Hafenstein, Carmen Mirabelli, Johan Neyts Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid published pages: e1007760, ISSN: 1553-7374, DOI: 10.1371/journal.ppat.1007760 |
PLOS Pathogens 15/5 | 2019-10-03 |
2019 |
Jim Baggen, Yue Liu, Heyrhyoung Lyoo, Arno L. W. van Vliet, Maryam Wahedi, Jost W. de Bruin, Richard W. Roberts, Pieter Overduin, Adam Meijer, Michael G. Rossmann, Hendrik Jan Thibaut, Frank J. M. van Kuppeveld Bypassing pan-enterovirus host factor PLA2G16 published pages: 3171, ISSN: 2041-1723, DOI: 10.1038/s41467-019-11256-z |
Nature Communications 10/1 | 2019-10-03 |
2019 |
Natacha S. Ogando, Francois Ferron, Etienne Decroly, Bruno Canard, Clara C. Posthuma, Eric J. Snijder The Curious Case of the Nidovirus Exoribonuclease: Its Role in RNA Synthesis and Replication Fidelity published pages: , ISSN: 1664-302X, DOI: 10.3389/fmicb.2019.01813 |
Frontiers in Microbiology 10 | 2019-10-03 |
2018 |
Mike Bray, Graciela Andrei, Ester Ballana, Kara Carter, David Durantel, Brian Gentry, Zlatko Janeba, Jennifer Moffat, Clasien J. Oomen, Bart Tarbet, Eva Riveira-Muñoz, José. A. Esté Meeting report: 31st International Conference on Antiviral Research published pages: 88-102, ISSN: 0166-3542, DOI: 10.1016/j.antiviral.2018.08.002 |
Antiviral Research 158 | 2019-10-03 |
2019 |
Ana S. Ferreira-Ramos, Changqing Li, Cécilia Eydoux, Jean Marie Contreras, Christophe Morice, Gilles Quérat, Alba Gigante, MarÃa-Jesús Pérez Pérez, Marie-Louise Jung, Bruno Canard, Jean-Claude Guillemot, Etienne Decroly, Bruno Coutard Approved drugs screening against the nsP1 capping enzyme of Venezuelan equine encephalitis virus using an immuno-based assay published pages: 59-69, ISSN: 0166-3542, DOI: 10.1016/j.antiviral.2019.01.003 |
Antiviral Research 163 | 2019-10-03 |
2019 |
Lisa Bauer, Roberto Manganaro, Birgit Zonsics, Jeroen R. P. M. Strating, Priscila El Kazzi, Moira Lorenzo Lopez, Rachel Ulferts, Clara van Hoey, Maria J. Maté, Thierry Langer, Bruno Coutard, Andrea Brancale, Frank J. M. van Kuppeveld Fluoxetine Inhibits Enterovirus Replication by Targeting the Viral 2C Protein in a Stereospecific Manner published pages: 1609-1623, ISSN: 2373-8227, DOI: 10.1021/acsinfecdis.9b00179 |
ACS Infectious Diseases 5/9 | 2019-10-03 |
2019 |
Ji-seong Yoon, Gyudong Kim, Dnyandev B. Jarhad, Hong-Rae Kim, Young-Sup Shin, Shuhao Qu, Pramod K. Sahu, Hea Ok Kim, Hyuk Woo Lee, Su Bin Wang, Yun Jeong Kong, Tong-Shin Chang, Natacha S. Ogando, Kristina Kovacikova, Eric J. Snijder, Clara C. Posthuma, Martijn J. van Hemert, Lak Shin Jeong Design, Synthesis, and Anti-RNA Virus Activity of 6′-Fluorinated-Aristeromycin Analogues published pages: 6346-6362, ISSN: 0022-2623, DOI: 10.1021/acs.jmedchem.9b00781 |
Journal of Medicinal Chemistry 62/13 | 2019-10-03 |
2018 |
Pietro Scaturro, Alexey Stukalov, Darya A. Haas, Mirko Cortese, Kalina Draganova, Anna Płaszczyca, Ralf Bartenschlager, Magdalena Götz, Andreas Pichlmair An orthogonal proteomic survey uncovers novel Zika virus host factors published pages: 253-257, ISSN: 0028-0836, DOI: 10.1038/s41586-018-0484-5 |
Nature 561/7722 | 2019-09-20 |
2019 |
Heyrhyoung Lyoo, Hilde M. van der Schaar, Cristina M. Dorobantu, Huib H. Rabouw, Jeroen R. P. M. Strating, Frank J. M. van Kuppeveld ACBD3 Is an Essential Pan-enterovirus Host Factor That Mediates the Interaction between Viral 3A Protein and Cellular Protein PI4KB published pages: , ISSN: 2150-7511, DOI: 10.1128/mBio.02742-18 |
mBio 10/1 | 2019-09-20 |
2019 |
Anna PÅ‚aszczyca, Pietro Scaturro, Christopher John Neufeldt, Mirko Cortese, Berati Cerikan, Salvatore Ferla, Andrea Brancale, Andreas Pichlmair, Ralf Bartenschlager A novel interaction between dengue virus nonstructural protein 1 and the NS4A-2K-4B precursor is required for viral RNA replication but not for formation of the membranous replication organelle published pages: e1007736, ISSN: 1553-7374, DOI: 10.1371/journal.ppat.1007736 |
PLOS Pathogens 15/5 | 2019-09-20 |
2018 |
C. E. Melia, H. M. van der Schaar, A. W. M. de Jong, H. R. Lyoo, E. J. Snijder, A. J. Koster, F. J. M. van Kuppeveld, M. Bárcena The Origin, Dynamic Morphology, and PI4P-Independent Formation of Encephalomyocarditis Virus Replication Organelles published pages: e00420-18, ISSN: 2150-7511, DOI: 10.1128/mbio.00420-18 |
mBio 9/2 | 2019-08-06 |
2018 |
Lanko, Kristina; Ma, Yipeng; Delang, Leen; Mirabelli, Carmen; Neyts, Johan Antiviral effects of selected nucleoside analogs against human parechoviruses A1 and A3 published pages: , ISSN: 0166-3542, DOI: 10.1016/j.antiviral.2018.12.009 |
Lirias 1 | 2019-08-06 |
2018 |
Angelica Corcuera, Katharina Stolle, Stefan Hillmer, Stefan Seitz, Ji-Young Lee, Ralf Bartenschlager, Alexander Birkmann, Andreas Urban Novel non-heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro published pages: 135-142, ISSN: 0166-3542, DOI: 10.1016/j.antiviral.2018.07.011 |
Antiviral Research 158 | 2019-05-22 |
2018 |
Lisa Bauer, Salvatore Ferla, Sarah A. Head, Shridhar Bhat, Kalyan K. Pasunooti, Wei Q. Shi, Lucian Albulescu, Jun O. Liu, Andrea Brancale, Frank J.M. van Kuppeveld, Jeroen R.P.M. Strating Structure-activity relationship study of itraconazole, a broad-range inhibitor of picornavirus replication that targets oxysterol-binding protein (OSBP) published pages: 55-63, ISSN: 0166-3542, DOI: 10.1016/j.antiviral.2018.05.010 |
Antiviral Research 156 | 2019-05-22 |
2018 |
Maximilian Münster, Anna Płaszczyca, Mirko Cortese, Christopher Neufeldt, Sarah Goellner, Gang Long, Ralf Bartenschlager A Reverse Genetics System for Zika Virus Based on a Simple Molecular Cloning Strategy published pages: 368, ISSN: 1999-4915, DOI: 10.3390/v10070368 |
Viruses 10/7 | 2019-05-22 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ANTIVIRALS" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "ANTIVIRALS" are provided by the European Opendata Portal: CORDIS opendata.